730 Central Avenue
Murray Hill , NJ 07974
USA
Related Content
September 26, 2016 — C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational ...
September 26, 2016
Feature | Peripheral Artery Disease (PAD)| Dave Fornell
It is estimated that more than 10 million people in the United States are affected by peripheral arterial disease (PAD) ...
February 22, 2016November 4, 2015 — C.R. Bard Inc. announced in late September that it has entered into a definitive agreement to acquire ...
November 04, 2015
October 15, 2015 — C. R. Bard Inc. announced the presentation of the 12-month results from the Lutonix Global Real-World ...
October 15, 2015
July 8, 2015 - C.R. Bard Inc. announced the publication of results from the LEVANT 2 study in the June 24, 2015, online ...
July 08, 2015
June 11, 2015 - C.R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved the ...
June 11, 2015
February 23, 2015 — C. R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has ...
February 23, 2015
October 13, 2014 — C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix 035 ...
October 13, 2014
September 30, 2014 — Coquà RadioPharmaceuticals Corp. is working to become the first commercial producer of lifesaving ...
September 30, 2014
June 16, 2014 — C. R. Bard Inc. announced that the U.S. Food and Drug Administration’s (FDA) Circulatory System Devices ...
June 16, 2014